Conglomerates
Compare Stocks
4 / 10Stock Comparison
MMM vs CAT vs HON vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Conglomerates
Industrial - Machinery
MMM vs CAT vs HON vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Conglomerates | Agricultural - Machinery | Conglomerates | Industrial - Machinery |
| Market Cap | $76.43B | $431.16B | $137.39B | $83.18B |
| Revenue (TTM) | $25.02B | $70.75B | $36.76B | $18.32B |
| Net Income (TTM) | $2.79B | $9.42B | $4.10B | $2.44B |
| Gross Margin | 39.5% | 32.5% | 36.9% | 39.4% |
| Operating Margin | 19.6% | 16.6% | 14.9% | 19.4% |
| Forward P/E | 16.9x | 40.1x | 20.6x | 22.8x |
| Total Debt | $12.94B | $43.33B | $34.58B | $13.76B |
| Cash & Equiv. | $5.24B | $9.98B | $12.49B | $1.54B |
MMM vs CAT vs HON vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| 3M Company (MMM) | 100 | 112.0 | +12.0% |
| Caterpillar Inc. (CAT) | 100 | 771.4 | +671.4% |
| Honeywell Internati… (HON) | 100 | 148.7 | +48.7% |
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MMM vs CAT vs HON vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MMM is the clearest fit if your priority is value.
- Lower P/E (16.9x vs 22.8x)
CAT is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 4.3%, EPS growth -14.6%, 3Y rev CAGR 4.4%
- 12.2% 10Y total return vs EMR's 215.5%
- PEG 1.43 vs HON's 11.22
- +190.7% vs HON's +5.5%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- 7.8% revenue growth vs MMM's 1.5%
EMR is the clearest fit if your priority is quality.
- 13.3% margin vs MMM's 11.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs MMM's 1.5% | |
| Value | Lower P/E (16.9x vs 22.8x) | |
| Quality / Margins | 13.3% margin vs MMM's 11.1% | |
| Stability / Safety | Beta 0.74 vs CAT's 1.54 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.4% | |
| Momentum (1Y) | +190.7% vs HON's +5.5% | |
| Efficiency (ROA) | 10.0% ROA vs HON's 5.3%, ROIC 15.9% vs 12.6% |
MMM vs CAT vs HON vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MMM vs CAT vs HON vs EMR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MMM leads in 2 of 6 categories
CAT leads 1 • HON leads 0 • EMR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MMM and CAT and EMR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CAT is the larger business by revenue, generating $70.8B annually — 3.9x EMR's $18.3B. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.1% (MMM). On growth, CAT holds the edge at +22.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $25.0B | $70.8B | $36.8B | $18.3B |
| EBITDAEarnings before interest/tax | $5.2B | $14.0B | $6.5B | $4.7B |
| Net IncomeAfter-tax profit | $2.8B | $9.4B | $4.1B | $2.4B |
| Free Cash FlowCash after capex | $2.1B | $11.4B | $4.2B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +39.5% | +32.5% | +36.9% | +39.4% |
| Operating MarginEBIT ÷ Revenue | +19.6% | +16.6% | +14.9% | +19.4% |
| Net MarginNet income ÷ Revenue | +11.1% | +13.3% | +11.2% | +13.3% |
| FCF MarginFCF ÷ Revenue | +8.2% | +16.2% | +11.4% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.3% | +22.2% | -6.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -39.7% | +30.2% | -41.9% | +28.2% |
Valuation Metrics
MMM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, MMM trades at a 50% valuation discount to CAT's 49.2x P/E. Adjusting for growth (PEG ratio), CAT offers better value at 1.75x vs HON's 16.04x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $76.4B | $431.2B | $137.4B | $83.2B |
| Enterprise ValueMkt cap + debt − cash | $84.1B | $464.5B | $159.5B | $95.4B |
| Trailing P/EPrice ÷ TTM EPS | 24.42x | 49.21x | 29.46x | 36.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.87x | 40.13x | 20.60x | 22.77x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.75x | 16.04x | 8.11x |
| EV / EBITDAEnterprise value multiple | 15.46x | 34.48x | 20.05x | 18.89x |
| Price / SalesMarket cap ÷ Revenue | 3.06x | 6.38x | 3.67x | 4.62x |
| Price / BookPrice ÷ Book value/share | 16.64x | 20.39x | 9.03x | 4.13x |
| Price / FCFMarket cap ÷ FCF | 54.75x | 41.97x | 25.48x | 31.19x |
Profitability & Efficiency
MMM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MMM delivers a 65.3% return on equity — every $100 of shareholder capital generates $65 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMM's 2.73x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs CAT's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +65.3% | +47.5% | +23.1% | +12.1% |
| ROA (TTM)Return on assets | +7.5% | +10.0% | +5.3% | +5.8% |
| ROICReturn on invested capital | +28.1% | +15.9% | +12.6% | +8.2% |
| ROCEReturn on capital employed | +16.1% | +19.1% | +12.6% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 2.73x | 2.03x | 2.24x | 0.68x |
| Net DebtTotal debt minus cash | $7.7B | $33.4B | $22.1B | $12.2B |
| Cash & Equiv.Liquid assets | $5.2B | $10.0B | $12.5B | $1.5B |
| Total DebtShort + long-term debt | $12.9B | $43.3B | $34.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 6.52x | 9.22x | 3.92x | 6.61x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $40,189 today (with dividends reinvested), compared to $9,887 for MMM. Over the past 12 months, CAT leads with a +190.7% total return vs HON's +5.5%. The 3-year compound annual growth rate (CAGR) favors CAT at 63.8% vs HON's 5.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.0% | +55.4% | +11.3% | +9.3% |
| 1-Year ReturnPast 12 months | +8.3% | +190.7% | +5.5% | +39.9% |
| 3-Year ReturnCumulative with dividends | +83.9% | +339.3% | +16.6% | +84.1% |
| 5-Year ReturnCumulative with dividends | -1.1% | +301.9% | +3.6% | +69.0% |
| 10-Year ReturnCumulative with dividends | +34.2% | +1223.1% | +134.6% | +215.5% |
| CAGR (3Y)Annualised 3-year return | +22.5% | +63.8% | +5.2% | +22.6% |
Risk & Volatility
Evenly matched — CAT and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than CAT's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAT currently trades 99.6% from its 52-week high vs MMM's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 1.54x | 0.74x | 1.52x |
| 52-Week HighHighest price in past year | $177.41 | $930.41 | $248.18 | $165.15 |
| 52-Week LowLowest price in past year | $137.63 | $318.11 | $186.76 | $106.53 |
| % of 52W HighCurrent price vs 52-week peak | +82.6% | +99.6% | +87.4% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 40.7 | 73.7 | 32.3 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 3.6M | 2.4M | 3.7M | 2.8M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MMM as "Hold", CAT as "Buy", HON as "Buy", EMR as "Buy". Consensus price targets imply 13.8% upside for MMM (target: $167) vs -11.0% for CAT (target: $825). For income investors, HON offers the higher dividend yield at 2.14% vs CAT's 0.63%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.75 | $824.80 | $243.83 | $161.92 |
| # AnalystsCovering analysts | 33 | 53 | 28 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +0.6% | +2.1% | +1.4% |
| Dividend StreakConsecutive years of raises | 0 | 8 | 15 | 37 |
| Dividend / ShareAnnual DPS | $2.18 | $5.86 | $4.63 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.3% | +1.2% | +2.8% | +1.5% |
MMM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CAT leads in 1 (Total Returns). 3 tied.
MMM vs CAT vs HON vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MMM or CAT or HON or EMR a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 1. 5% for 3M Company (MMM). 3M Company (MMM) offers the better valuation at 24. 4x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate Caterpillar Inc. (CAT) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MMM or CAT or HON or EMR?
On trailing P/E, 3M Company (MMM) is the cheapest at 24.
4x versus Caterpillar Inc. at 49. 2x. On forward P/E, 3M Company is actually cheaper at 16. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Caterpillar Inc. wins at 1. 43x versus Honeywell International Inc. 's 11. 22x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MMM or CAT or HON or EMR?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +301. 9%, compared to -1. 1% for 3M Company (MMM). Over 10 years, the gap is even starker: CAT returned +1223% versus MMM's +34. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MMM or CAT or HON or EMR?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Caterpillar Inc. 's 1. 54β — meaning CAT is approximately 108% more volatile than HON relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 3% for 3M Company — giving it more financial flexibility in a downturn.
05Which is growing faster — MMM or CAT or HON or EMR?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus 1. 5% for 3M Company (MMM). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -20. 5% for 3M Company. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MMM or CAT or HON or EMR?
Caterpillar Inc.
(CAT) is the more profitable company, earning 13. 1% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 13. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 16. 6% for CAT. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MMM or CAT or HON or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Caterpillar Inc. (CAT) is the more undervalued stock at a PEG of 1. 43x versus Honeywell International Inc. 's 11. 22x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, 3M Company (MMM) trades at 16. 9x forward P/E versus 40. 1x for Caterpillar Inc. — 23. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMM: 13. 8% to $166. 75.
08Which pays a better dividend — MMM or CAT or HON or EMR?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 6% for Caterpillar Inc. (CAT).
09Is MMM or CAT or HON or EMR better for a retirement portfolio?
For long-horizon retirement investors, Caterpillar Inc.
(CAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 6% yield, +1223% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAT: +1223%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MMM and CAT and HON and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.